Showing results (1331-1340 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|January 21, 2010
Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systemsTania Stafinski, Christopher J McCabe, Devidas Menon
Pharmacoeconomics|September 18, 2016
Economic Evaluations of First-Line Chemotherapy Regimens for Pancreatic Cancer: A Critical ReviewMahdi Gharaibeh, J Lyle Bootman, Ali McBride, et al.
Pharmacoeconomics|May 11, 2017
A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness ModelsChase Hollman, Mike Paulden, Petros Pechlivanoglou, et al.
Pharmacoeconomics|May 7, 2017
Defining and Measuring the Affordability of New Medicines: A Systematic ReviewFernando Antoñanzas, Robert Terkola, Paul M Overton, et al.
Pharmacoeconomics|April 14, 2018
Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of RifaximinGuy Neff, Woodie Zachry
Pharmacoeconomics|July 5, 2017
Reporting and Analysis of Trial-Based Cost-Effectiveness Evaluations in Obstetrics and GynaecologyMohamed El Alili, Johanna M van Dongen, Judith A F Huirne, et al.
Pharmacoeconomics|July 3, 2017
Validation of a DICE Simulation Against a Discrete Event Simulation Implemented Entirely in CodeJörgen Möller, Sarah Davis, Matt Stevenson, et al.
Pharmacoeconomics|September 5, 2016
Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and RecommendationsSimon van der Schans, Lucas M A Goossens, Melinde R S Boland, et al.
Pharmacoeconomics|April 20, 2018
Effects of County Public Hospital Reform on Procurement Costs and Volume of Antibiotics: A Quasi-Natural Experiment in Hubei Province, ChinaYuqing Tang, Chaojie Liu, Junjie Liu, et al.
Pharmacoeconomics|May 1, 2018
Cost-Effectiveness of Second-Line Endocrine Therapies in Postmenopausal Women with Hormone Receptor-positive and Human Epidermal Growth Factor Receptor 2-negative Metastatic Breast Cancer in JapanVerin Lertjanyakun, Nathorn Chaiyakunapruk, Susumu Kunisawa, et al.
Pageof 336